LY3938577
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
November 27, 2025
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
(clinicaltrials.gov)
- P2 | N=100 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
November 20, 2025
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
(clinicaltrials.gov)
- P1 | N=118 | Recruiting | Sponsor: Eli Lilly and Company | N=70 ➔ 118 | Trial completion date: Oct 2025 ➔ Oct 2026 | Trial primary completion date: Oct 2025 ➔ Oct 2026
Enrollment change • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
October 16, 2025
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
(clinicaltrials.gov)
- P2 | N=100 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
March 03, 2025
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
(clinicaltrials.gov)
- P1 | N=70 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Apr 2025 ➔ Jul 2025 | Trial primary completion date: Apr 2025 ➔ Jul 2025
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
July 24, 2024
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P1 | N=66 | Completed | Sponsor: Eli Lilly and Company | Recruiting ➔ Completed
Trial completion • Diabetes • Hypoglycemia • Metabolic Disorders • Type 2 Diabetes Mellitus
May 31, 2024
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
(clinicaltrials.gov)
- P1 | N=70 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
February 28, 2024
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
(clinicaltrials.gov)
- P1 | N=70 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P1 trial • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
January 03, 2024
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P1 | N=88 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetes • Hypoglycemia • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 8
Of
8
Go to page
1